Patents Assigned to ZalVac AB
  • Microparticles from as vaccine antigens
    Patent number: 11844829
    Abstract: An isolated Streptococcus pneumoniae membrane vesicle microparticle (MP), wherein said MP comprises: the protein Ply at the level of ?0.070 ?g/?g total protein in the MP; and/or the protein LytA at the level of ?0.070 ?g/?g total protein in the MP; and/or the protein PspC at the level of ?0.130 ?g/?g total protein in the MP; and/or the protein RrgB at the level of ?0.020 ?g/?g total protein in the MP. Compositions comprising such MPs. Uses thereof in particular in immunization, as well as methods of manufacture thereof.
    Type: Grant
    Filed: December 21, 2017
    Date of Patent: December 19, 2023
    Assignee: ZalVac AB
    Inventors: Birgitta Henriques Normark, Mario Codemo, Federico Iovino, Sandra Muschiol, Staffan Normark, Sun Nyunt Wai